pharmaphorum| News & views on pharma and biotech’s evolving future

R&D

steaming nebulizer mask in hand instructing African American daughter

Sponsored

Advancing RSV and hMPV research through human challenge tria...

Human challenge trials offer a complementary approach, and hVIVO has been at the forefront of this field for decades.

News

UK seeks views on indefinite CE marks for medical devices

The UK has launched a consultation asking whether medical devices with CE marks issued in the EU and sold in GB should be recognised indefinitely.

Market Access

EVERSANA leaders on digital-first models, affordability, and...

News

Roche trial offers hope to patients with rare kidney disease

A study of Roche's Gazyva has raised the prospect of a first approved therapy for the rare kidney disorder primary membranous nephropathy.

News

AI in drug development news round-up

Recent developments in biopharma AI include an alliance between Thermo and Datavant, plus news from Insilico, Evinova, BPGbio, Evogene, and AMPLY.

Featured Content

Digital

Tel Aviv Sourasky Medical Center helipad and The Jerusalem Press Club

Israel’s MedTech and health innovation landscape: Part one –...

Part One of a series of articles – Israel’s MedTech and health innovation landscape: From Tel Aviv to Jerusalem - looking at resilient progress there.

Market Access

EVERSANA leaders on digital-first models, affordability, and...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Sales & Marketing

Sponsored

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Patients

pharmaphorum podcast Episode 244, Jeff Harper, Intelliguard

On addressing drug waste and ensuring access, with Jeff Harp...

The rising cost of drugs in 2025 was driven by several factors, including inflation, supply chain issues, and the demand for specialty drugs.

Patients

Interview at JPM26 with Alexander Schneider

New hope for ovarian cancer, with Alexander Schneider

Alexander Schneider, CEO of CureLab Oncology, shares how his company’s drug candidate for platinum-resistant ovarian cancer is named after his wife.

Digital

Sponsored

Expert Directed Applied Intelligence: Redefining AI in Life ...

In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.

Newsletters and Deep Dive
digital magazine

Latest News

News

UK seeks views on indefinite CE marks for medical devices

The UK has launched a consultation asking whether medical devices with CE marks issued in the EU and sold in GB should be recognised indefinitely.

News

Roche trial offers hope to patients with rare kidney disease

A study of Roche's Gazyva has raised the prospect of a first approved therapy for the rare kidney disorder primary membranous nephropathy.

News

AI in drug development news round-up

Recent developments in biopharma AI include an alliance between Thermo and Datavant, plus news from Insilico, Evinova, BPGbio, Evogene, and AMPLY.

News

FDA turns down 'national priority' drug from Disc Medicine

One of the beneficiaries of the FDA's national priority vouchers, Disc Medicine, has had its marketing application turned down by the regulator.

Views & Analysis

Digital

Israel’s MedTech and health innovation landscape: Part one –...

Part One of a series of articles – Israel’s MedTech and health innovation landscape: From Tel Aviv to Jerusalem - looking at resilient progress there.

R&D

Representation of bipolar and other mental health disorders, Janus concept

The role of the opioid pathway in schizophrenia and bipolar ...

Psychiatry has spent decades focused on dopamine, serotonin, norepinephrine, and glutamate.

Digital

Man shakes woman's hand in signal of a business deal

Changing Faces: Digital and supplier, January 2026

The life sciences supplier and digital health sectors witnessed significant leadership movements in January.

R&D

Sponsored

Advancing RSV and hMPV research through human challenge tria...

Human challenge trials offer a complementary approach, and hVIVO has been at the forefront of this field for decades.

Deep Dive

Market Access

Equity and Sustainability

Market Access

Mapping the pharma sector's path to net zero

Market Access

Pharma’s determined shift to more sustainable logistics

Market Access

Inside Sandoz: How women leaders are driving sustainability ...

White Papers & Webinar

Sales & Marketing

Sponsored

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Digital

Sponsored

Expert Directed Applied Intelligence: Redefining AI in Life ...

In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.

Sales & Marketing

Lumanity white paper - person at top of mountain range

Sponsored

The strategic imperative of Integrated Evidence Generation P...

Integrated Evidence Generation Planning (IEGP) is recognised as a strategic necessity for biopharmaceutical organisations.

Digital

White paper from Veeva on Clinical Data Industry Research

Sponsored

Data managers and CRAs warn of rising data quality risks due...

A new industry report uncovers the scope of a long-ignored problem in clinical trial operations.

Podcasts & Video

Patients

New hope for ovarian cancer, with Alexander Schneider

Alexander Schneider, CEO of CureLab Oncology, shares how his company’s drug candidate for platinum-resistant ovarian cancer is named after his wife.

Patients

Precision medicine in action, with Cary Claiborne

Cary Claiborne, CEO of Adial Pharmaceuticals, discusses his company’s bet on a precision treatment for AUD.

Patients

On addressing drug waste and ensuring access, with Jeff Harp...

The rising cost of drugs in 2025 was driven by several factors, including inflation, supply chain issues, and the demand for specialty drugs.

R&D

Treating the chronic diseases GLP-1s miss, with Laurent Auda...

Prive Bio CEO Laurent Audaly spoke with pharmaphorum during the JP Morgan Healthcare conference, discussing GLP-1s in the cardiometabolic space.

Partner Content

Press Releases

Partner Content

The PM Society Launches Pharmony to Support More Effective P...

The Pharmaceutical Marketing Society (PM Society) today announces the launch of Pharmony

Partner Content

EVERSANA Names Monica Avram Executive Vice President and Chi...

As chief legal officer and a member of the Executive Leadership Team, Monica Avram leads EVERSANA's global Legal and Compliance function.

R&D

Emerging Trends in Personalised Medicine at PHARMAP 2026

Partner Content

Featured Content

Editor's Picks

Latest News

Views & Analysis

Deep Dive

White Papers & Webinar

Podcasts & Video

Partner Content